ctrl K

Watchlist Price Alert

Immuneering Corporation (IMRX)

NASDAQ: IMRX · Real-Time Price · USD

2.36

0.46 (24.21%)

At close: Jun 16, 2025, 3:59 PM

2.56

8.47%

Pre-market: Jun 17, 2025, 08:59 AM EDT

Immuneering Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	316.95K	2.08M	2.31M	1.92M
Cost of Revenue	n/a	764.14K	158.12K	1.15M	1.28M	1.22M
Gross Profit	n/a	-764.14K	158.83K	926.89K	1.03M	696.74K
Operating Income	-64.07M	-58.41M	-51.74M	-33.89M	-17.08M	-6.29M
Interest Income	n/a	3.61M	1.01M	169.9K	42.66K	57.66K
Pretax Income	-61.04M	-53.47M	-50.51M	-33.84M	-17.04M	-7.71M
Net Income	-61.04M	-53.47M	-49.28M	-33.54M	-17.04M	-8.06M
Selling & General & Admin	16.08M	16.25M	15.61M	8.27M	3.11M	2.71M
Research & Development	47.96M	41.4M	36.27M	26.54M	15M	4.28M
Other Expenses	29.27K	n/a	30.05K	-127.06K	n/a	n/a
Operating Expenses	64.07M	57.65M	51.9M	34.81M	18.11M	6.99M
Interest Expense	n/a	n/a	1.01M	n/a	n/a	351.3K
Selling & Marketing Expenses	n/a	-511.87K	n/a	n/a	n/a	n/a
Cost & Expenses	64.07M	58.41M	52.06M	35.97M	19.39M	8.21M
Income Tax Expense	n/a	n/a	-1.23M	-307.49K	-84.34K	351.3K
Shares Outstanding (Basic)	29.98M	28.42M	26.39M	26.32M	25.51M	25.51M
Shares Outstanding (Diluted)	29.98M	28.42M	26.39M	26.32M	25.51M	25.51M
EPS (Basic)	-2.04	-1.88	-1.87	-1.27	-0.67	-0.32
EPS (Diluted)	-2.04	-1.88	-1.87	-1.27	-0.67	-0.32
EBITDA	-63.69M	-58.06M	-51.47M	-33.68M	-17M	-7.34M
EBIT	-64.07M	-58.41M	-51.75M	-33.89M	-17.08M	-7.36M
Depreciation & Amortization	385.07K	352.08K	796.79K	159.07K	79.31K	18.08K